Avecris is a groundbreaking brand revolutionizing genetic medicine with their innovative SPRING DNA platform. With a vision to improve human health and create transformative medicines, Avecris is committed to unlocking the power of SPRING. This platform, developed by a team of gene delivery experts, offers a unique and proprietary DNA vector structure that enables enhanced delivery and expression.

The SPRING DNA template features flexible spring-like loop designs, allowing for tissue-specific targeting with the addition of helper functions like antibodies and peptides. Not only is SPRING DNA more stable than other forms of RNA, but it also provides long-lasting protein expression for effective treatment of chronic diseases. Avecris has also developed an innovative on/off switch to precisely control gene expression in specific cell types.

With scalable production processes, SPRING DNA has the potential to make gene therapy and genetic vaccination more affordable and accessible. Exciting things are on the horizon with Avecris leading the way in modern genetic medicine